Detailed Information on Publication Record
2008
Employment of electrochemical techniques for metallothionein determination in tumor cell lines and patients with a tumor disease
FABRIK, Ivo, Soňa KŘÍŽKOVÁ, Dalibor HÚSKA, Vojtěch ADAM, Jaromír HUBÁLEK et. al.Basic information
Original name
Employment of electrochemical techniques for metallothionein determination in tumor cell lines and patients with a tumor disease
Name in Czech
Využití elektrochemických metod pro stanovení metallothioneinu v nádorových buněčných liniích a u pacientů s nádorovým onemocněním
Authors
FABRIK, Ivo (203 Czech Republic), Soňa KŘÍŽKOVÁ (203 Czech Republic), Dalibor HÚSKA (203 Czech Republic), Vojtěch ADAM (203 Czech Republic), Jaromír HUBÁLEK (203 Czech Republic), Libuše TRNKOVÁ (203 Czech Republic), Tomáš ECKSCHLAGER (203 Czech Republic), Jiří KUKAČKA (203 Czech Republic), Richard PRŮŠA (203 Czech Republic) and René KIZEK (203 Czech Republic, guarantor)
Edition
Electroanalysis, Weinheim, Germany, Wiley VCH Verlag GmbH, 2008, 1040-0397
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
10405 Electrochemistry
Country of publisher
Germany
Confidentiality degree
není předmětem státního či obchodního tajemství
Impact factor
Impact factor: 2.901
RIV identification code
RIV/00216224:14310/08:00028433
Organization unit
Faculty of Science
UT WoS
000258087300003
Keywords in English
chromatography; tumor cells; electrochemistry; metallothionein
Změněno: 14/7/2009 15:45, prof. RNDr. Libuše Trnková, CSc.
V originále
In the present paper we employed adsorptive transfer stripping technique coupled with chronopotentiometric stripping analysis for determination of metallothionein (MT) in tumor cell lines and differential pulse voltammetry Brdicka reaction for determination of MT in blood serum of patients with head and neck cancer or retinoblastoma, and of rats treated with cisplatin with respect to discuss the role of MT in formation of resistance on treatment with heavy metal based cytostatics. The cisplatin or carboplatin sensitive and resistant neuroblastoma cell lines were derived from the maternal cell line isolated from the bone metastasis of patients with neuroblastoma. Based on the results obtained it can be concluded that level of MT increases with higher dose of platinum based cytostatics at cells. Further we focused on determination of MT in blood serum of rats treated with cisplatin (two doses 1.05 mg and/or 2.1 mg of cisplatin per kg). The highest level of MT at rats treated with 1.05 mg cisplatin was determined after four hours as 4.9 mol/L. In the case of the second experimental group the maximum was reached even after two hours of the treatment as 4.8 mol/L. In addition we were interested in the effect of cisplatin or carboplatin treatment of patients with a tumor disease. At patients with tumor in head and neck area treated with cisplatin we observed that the level of MT was going higher due to administration of the drug. This phenomenon was observed at all patients. However at patients with retinoblastoma treated with carboplatin we observed various phenomena including decreasing, increasing or no changes in MT level. Progression of MT levels was therefore individual and probably depended on tumor resistance to carboplatin.
In Czech
Stanovení metallothioneinu v nádorových buněčných liniích a v séru pacientů.
Links
IAA401990701, research and development project |
|